HIGHLIGHTS
- who: Manuela Simonato and collaborators from the Department of Pharmaceutical and Pharmacological Sciences, University of Padua, Padua, Italy have published the paper: Tryptophan Metabolites, Cytokines, and Fatty Acid Binding Protein 2 in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, in the Journal: (JOURNAL) of 31/06/2018
- what: We found substantial heterogeneity among patients with ME/CFS; however, in spite of many differences, patients shared traits of possible significance for the explanation of their symptoms.
- how: The authors thus decided to subject them to a trial of drugs used in autoinflammatory syndromes such as colchicine . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.